Canada markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.75-0.41 (-0.93%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
5,375
7,418
3,573
9,538
12,743
Operating Expenses
Research Development
43,559
42,534
42,672
66,449
96,171
Selling General and Administrative
14,911
14,456
15,426
19,269
25,003
Total Operating Expenses
58,470
56,990
58,098
85,942
122,070
Operating Income or Loss
-53,095
-49,572
-54,525
-76,404
-109,327
Total Other Income/Expenses Net
-11,765
-11,375
3,647
-75,545
-7,986
Income Before Tax
-64,860
-60,947
-50,878
-151,949
-117,313
Income Tax Expense
-
-1,167
0
-765
-24,282
Income from Continuing Operations
-63,693
-59,780
-50,878
-151,184
-93,031
Net Income
-63,693
-59,780
-50,878
-151,184
-93,031
Net Income available to common shareholders
-63,693
-59,780
-50,878
-151,184
-93,031
Basic EPS
-
-2.02
-3.51
-14.48
-10.80
Diluted EPS
-
-2.02
-3.51
-14.48
-10.80
Basic Average Shares
-
29,640
14,507
10,442
8,570
Diluted Average Shares
-
29,640
14,507
10,442
8,570
EBITDA
-
-45,643
-49,667
-72,603
-104,017